Clinical trials
Vaccination clinical trials
Below are recruiting vaccination clinical trials, each written for real people, not researchers. We’re tracking 575 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06675201RecruitingPhase 2
Personalized vaccine for advanced esophageal cancer after treatment
This trial tests a personalized vaccine made from your tumor's unique markers (neoantigens) to help prevent your advanced esophageal cancer from coming back. It's for people who have already completed strong treatment and are currently cancer-free, but have a high risk of recurrence.
Chengdu, Please SelectAges 18–80 - NCT07648953Recruiting
HPV Vaccine Education Videos for Cancer Survivors
This study tests short educational videos on Facebook to help young cancer survivors complete their HPV vaccine series. The HPV vaccine protects against certain cancers, and this trial aims to see if videos can help more survivors get vaccinated.
Salt Lake City, UtahAges 18–26 - NCT07648069RecruitingPhase 1
Personalized Cancer Vaccine Plus Immune Cell Therapy for Advanced Sarcoma
This study tests a personalized vaccine made from your tumor's unique mutations, combined with special immune cells grown from your blood, to treat advanced sarcoma (bone or soft tissue cancer) that did not respond to initial treatment. The goal is to help your immune system recognize and attack cancer cells.
Guangzhou, GuangdongAges 18–70 - NCT06734832RecruitingPhase 3
Vaccine trial for hand, foot, and mouth disease
This trial tests a new two-in-one vaccine to protect children against hand, foot, and mouth disease caused by two common viruses (EV71 and CA16). It is for healthy kids ages 6 months to 5 years and will check if the vaccine is safe and works well.
Hefei, AnhuiAges 6 months–5.9 years - NCT07509047RecruitingPhase 2
Cholera vaccine safety study for adults and children
This trial tests a new cholera vaccine in healthy people ages 1 to 45. It aims to see if the vaccine is safe and creates a good immune response.
Nairobi, Kenyatta National Hospital ComplexAges 1–45 - NCT07500207Enrolling by invitationPhase 3
Rabies vaccine trial for people aged 10 to 60
This trial tests a new lyophilized rabies vaccine to see how well it works and how safe it is. It is for people who have not been vaccinated against rabies recently and have not been bitten or scratched by an animal that broke the skin in the past year.
Neijiang, SichuanAges 10–60 - NCT07473999Recruiting
Vaccine protection in transplant recipients
This study looks at how well vaccines work in people who have received a bone marrow or solid organ transplant. Researchers will track infections and outcomes to understand vaccine effectiveness.
Pavia, LombardyAges Any age - NCT07460154Recruiting
Structured review to improve COPD management
This trial tests a structured review process to help people with COPD who have needed multiple steroid pills in the past year. It aims to improve care and prevent future harm from the condition.
North ShieldsAges 35 years+ - NCT07417488RecruitingPhase 1
Vaccine therapy for advanced colorectal and small bowel cancer
This trial tests a vaccine therapy for people with advanced colorectal or small bowel cancer that has spread or can't be removed. The vaccine targets a protein found on cancer cells to help your immune system fight the cancer.
Philadelphia, PennsylvaniaAges 18 years+ - NCT07347002Enrolling by invitation
Observational study of chikungunya vaccine effectiveness in Brazil
This study looks at how well the VLA1553 vaccine prevents chikungunya disease in parts of Brazil where the vaccine is being offered as part of a pilot program. If you live in one of those areas and have had symptoms that might be chikungunya, this study will use your health records and blood tests to check how effective the vaccine is.
Belo Horizonte, Minas GeraisAges 18–59 - NCT07348692RecruitingPhase 3
Pneumonia vaccine study for healthy infants 2 months old
This study tests a new vaccine that protects against 21 types of bacteria that cause pneumonia and other infections. It is for healthy infants around 2 months old to see if it works as well as the current vaccine.
Fayetteville, ArkansasAges 1 month–3 months - NCT06650956Recruiting
HPV vaccine and health education for teens in Laos
This trial offers HPV vaccination and sexual health education to 10-13 year old students and out-of-school youth in Laos. It aims to improve health knowledge and vaccination rates.
Muang Sing, ProvinceAges 10–13 - NCT07310472Recruiting
Nasal flu vaccine for children in daycare
This trial is testing a nasal spray flu vaccine given to children at their daycare or a healthcare facility. It aims to make getting the vaccine easier and more convenient for families.
TurkuAges 2–6 - NCT07302256RecruitingPhase 1
Flu vaccine trial for adults 60 and older
This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.
Wuhan, HubeiAges 60 years+ - NCT07304284RecruitingPhase 3
Cholera vaccine study for healthy adults and people with HIV
This trial tests a new cholera vaccine (Biovac OCV-S) to see if it works as well as the current vaccine (Euvichol-Plus). It is for healthy people aged 1 to 45, and also for adults with HIV who are on treatment.
Durban, Eastern CapeAges 1–45 - NCT06126822RecruitingPhase 3
Study of Ebola vaccine booster in previously vaccinated adults
This study tests if a booster dose of one of two Ebola vaccines (Ervebo® or Zabdeno®) is safe and works well in people who already got an Ebola vaccine more than 4 months ago. It's especially for people living in the Democratic Republic of Congo (DRC) who may have been vaccinated before and might need a stronger, longer-lasting immune response.
GomaAges 18–50 - NCT04970836Recruiting
Hepatitis B revaccination for young adults in Taiwan
This study looks at how well your immune system responds after getting 1–2 extra doses of the hepatitis B vaccine. It may help doctors understand who needs revaccination and how to strengthen protection.
TaipeiAges 20–36 - NCT06608199RecruitingPhase 3
Pneumonia vaccine study for healthy infants
This study tests a new pneumonia vaccine (PCV13) in healthy infants to see if it works as well as a current vaccine. It compares the immune response and safety of the two vaccines.
Denpasar, BaliAges 1 month–2 months - NCT07240558RecruitingPhase 3
Flu vaccine study for organ transplant patients
This study tests whether a special flu vaccine, designed for a future pandemic, works safely in people who have had an organ transplant. It aims to find a better way to protect transplant patients from severe flu.
Toronto, OntarioAges 18 years+ - NCT07243236Recruiting
Do vaccine funding help more patients get shots?
This study looks at whether funding from the French National Health Insurance helps more people get recommended vaccines. It focuses on adults who need the pneumococcal vaccine and pregnant women who need the pertussis (whooping cough) vaccine.
Paris, IDFAges 18 years+ - NCT06255626RecruitingPhase 1/Phase 2
New COVID-19 booster vaccine study
This trial tests a new type of COVID-19 booster vaccine that targets a protein to help your immune system. It's for people who already had a primary vaccine series and at least one mRNA booster, with the last booster at least 6 months ago.
CréteilAges 18–84 - NCT07192458RecruitingPhase 2
High vs. Standard Dose Flu Vaccine in Lung Transplant
This study compares a high-dose flu vaccine to the standard dose in lung transplant recipients. It aims to see if a higher dose gives better protection against the flu.
Nashville, TennesseeAges 18 years+ - NCT07156084RecruitingPhase 4
HPV vaccine long-term effect study for young adults
This study checks if one dose of the 9-valent HPV vaccine given at ages 9-11 still protects you 6 years later. It is for people who only had that single dose and no other HPV shots.
Québec, QuebecAges 15–17 - NCT07164144Enrolling by invitation
School Ambassadors for Vaccine Education
This trial tests whether training students as vaccine ambassadors can improve vaccine education in schools. It may help increase vaccine knowledge and uptake among students.
Rochester, New YorkAges 5–21
Hear when a new Vaccination trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for vaccination?
- Yes. Clin2 currently lists 575 recruiting vaccination studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a vaccination trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a vaccination trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.